RecruitingNCT05851898
Pilot study of duloxetine and depressive symptoms after fragility fractures
About this title
Read the official source — NCT05851898Medication studyAges 65+United StatesDepression
Understand this study
Who could participate?
Listed age limits: from 65 years.
- Listed locations
- Winston-SalemSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 8, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 100
- Sponsor
- Wake Forest University Health Sciences
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 65 Years
- Official registry ID
- NCT05851898
- Official title
Show the full official title
The Role of SNRI's in the Prophylaxis of Depression in the First Year Following Lower Extremity Fragility Fractures in Geriatric Patients
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Winston-Salem
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Wake Forest University Health Sciences, a university.
Does this study involve medication?
Yes. The study involves medication, including Duloxetine 30 mg.
Who can participate?
Listed age limits: from 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
